Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.
El Kholy
Noura M
NM
Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Ain Shams University, Abbasia, Cairo, Egypt.
Sallam
Maha M
MM
Ahmed
Manal B
MB
Sallam
Reem M
RM
Asfour
Inas A
IA
Hammouda
Jehad A
JA
Habib
Haidy Z
HZ
Abu-Zahra
Fatima
F
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D001752:Blast Crisis / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics; D016022:Case-Control Studies; D004317:Doxorubicin / Q000494:pharmacology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014364:Tryptophan / Q000031:analogs & derivatives* / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D000903:Antibiotics, Antineoplastic; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D012333:RNA, Messenger; D004317:Doxorubicin; D014364:Tryptophan; C525396:1-methyltryptophan